Journal
ACS NANO
Volume 13, Issue 12, Pages 13620-13626Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.9b08659
Keywords
-
Categories
Funding
- University of Toronto Clinician-Investigator Program
- Canada Research Chairs Program
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Terry Fox Research Institute
- Princess Margaret Cancer Foundation
Ask authors/readers for more resources
Nanomedicines have historically struggled to find clinical relevance and to achieve translation successfully. In this Perspective, we discuss possible reasons for this difficulty and highlight several key features of nanomedicines that are often overlooked by biomedical engineers. We present the notion of clinical multifunctionality as distinct from multifunctionality as it is traditionally described at the nanoscale and emphasize its importance through examples of nanomedicines that have demonstrated emergent clinical multifunctionality once translated. We also describe a phenomenon in which clinical multifunctionality results in diagonal translation after a nanomedicine is adopted by clinicians to serve as a solution for a clinical problem that it was not designed to solve. Biomedical engineers can take advantage of these phenomena to assist in achieving clinical translation of new nanomedicines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available